Global Bordetella Pertussis Infections Market Size showed healthy growth in the recent years and is anticipated to witness a steep rise by generating an estimated revenue of US$ XXXX over the forecast period. According to latest study conducted by our analysts and industry experts, global bordetella pertussis infections market is expected to grow at a CAGR of XX.XX% during the forecast period, i.e. 2017-2025.

Global Bordetella Pertussis Infections Market Opportunities Analysis, By 2017-2025

Pertussis also known as Whooping cough which is a disease caused by two different strains of small gram negative cocobacillus bacteria called Bordetella pertussis and Bordetella parapertussis. Whooping cough caused by Bordetella pertussis is more severe as compared to Bordetella parapertussis. Pertussis is caused when the pathogen infects the mucosal layers of the human respiratory tract. It is a contagious, and transfers through infected person to susceptible individual via tiny respiratory droplets. The bacteria incubates itself for 7 to 10 days before developing nose and throat inflammation and cough in the infected individual and within 1 to 2 weeks coughing spasms ending with ‘whoop’ sound may occur. Secondary symptoms may include pneumonia, subconjuctival hemorrhage, hypoxia, seizures and encephalopathy. Mostly small babies and children are affected by Bordetella pertussis, but adults may also get affected. This disease has long been responsible for mortality worldwide. Increased incidence of Bordetella pertussis infection in the human population and increased demand for the development of new pertussis vaccines will boost the market growth during the forecast period.

Bordetella Pertussis Infections Market Dynamics:

With peaks in reported disease every few years and frequent outbreaks even in the most developed nations, increased demand for better whole cell and acellular vaccines and reduced cost of vaccinations are some of the key driving factors which will lead Bordetella pertussis infections market growth.

Several complexities like injection site reactogenicity including swelling of arm, redness at the site of injection and fever in the whole cell pertussis vaccines. Whereas waning protection following acellular pertussis vaccination and decreased long term protection are some of the restraining factors for the growth of Bordetella pertussis infections market.

Bordetella Pertussis Infections Market Study Objectives

1. To forecast the market size of bordetella pertussis infections market, along with describing and defining the market, in terms of volume and revenue.

2. Market analysis and forecast of bordetella pertussis infections market on the basis of region, substrate and application or end-use industry.

3. To analyze and elaborate significant factors that will have major impact on the growth of bordetella pertussis infections market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of bordetella pertussis infections market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the bordetella pertussis infections market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

7. Analysis of market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

8. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

Bottom-up and top-down are two main approaches that were taken into account to anticipate and validate the market size of bordetella pertussis infections market, and to reach the anticipated market size of several dependent submarkets. The research and study involved massive utilization of secondary data sources, several directories, private and government websites, and authentic databases, to collect or gather market-oriented as well as technical information for the study of bordetella pertussis infections market commercially.

Bordetella Pertussis Infections Market Segmentation:  Based on Treatment Type:

Vaccination: Currently, there are two types of vaccination available in the market for Bordetella pertussis, i.e. whole-cell pertussis vaccination and acellular pertussis vaccination. Whole cell vaccination was the first vaccination against Bordetella pertussis. Whole-cell pertussis vaccine is composed of heat killed Bordetella pertussis pathogen and has approx. (88-90) % of efficacy according to World Health Organization. Whereas, the efficacy of acellular Bordetella pertussis vaccine against the pathogen is approx. (75-85) %.

Antimicrobial Agents: Bordetella pertussis treatment based on the type of antimicrobial agents used: Azithromycin, Clarithromycin and Erythromycin. Although, Azithromycin is preferred over Clarithromycin and Erythromycin due to its better response against the disease and less side effects.

Bordetella Pertussis Infections Market Regional Insights:

North America and Europe holds the largest market for Bordetella pertussis infections market. US and Canada from the North American continent and several other European countries including UK and France switched from using whole cell pertussis vaccines to acellular pertussis vaccines in the 1900s and has the largest market for acellular pertussis vaccines, i.e. DTaP. Although, acellular pertussis vaccines DTaP has a high level of vaccine coverage. The North American continent has experienced increased incidence of pertussis outbreaks in the recent years owing to the less effectiveness of the acellular pertussis vaccine DTaP in the longer run which has led to the development of adolescent and adult boosters which are required to stop further transmission of disease from adult to infants.

Under developed and developing countries in Asia Pacific and other regions holds the largest market for whole cell pertussis vaccine (DTwP). Due to its cost effectiveness and availability in the lower income regions.

Global Key Players

Some of the key market vendors licensed to manufacture Bordetella pertussis vaccinations and production of antimicrobial agents globally are Glaxo Smith Kline, Sanofi Pasteur, Pfizer, Novartis, Merck and Co, Roche, Jhonson & Jhonson and others.

Global Bordetella Pertussis Infections Market Report Offer You!

Global Bordetella Pertussis Infections Market size report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast.

The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.

Why You Should Choose us?
• We offer the best industry research services.
• Our panel of experts has tremendous experience in their respective fields
• We use advanced analytical tools to provide highly personalized industry intelligence research.
• We provide easy-to- use information.
• Qualitative and Quantitative market research
• Market size assessment across various segments
• Potential early warning signals posed by existing market players
• Providing benchmark metrics by comparing an organization across the industry
• Competitive assessment which may impact business and product evaluation
• Insights about government or legal changes that might impact market statistics
• Operational cost optimization strategies